This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Toxic effect of corrosive substances
ST19_TOXIC_EFFECT_CORROSIVE_SUBST
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
189 |
4. Check minimum number of eventsNone |
189 |
5. Include endpointsNone |
189 |
6. Filter based on genotype QC (FinnGen only) |
189 |
Control definitions (FinnGen only)
- Control exclude
- ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T5[1-9]|T6[0-5]
- Name in latin
- Effectus toxicus substantiarum corrosivarum
Similar endpoints
↥List of similar endpoints to
Toxic effect of corrosive substances
based on the number of shared cases.
Similar with more cases:
- Toxic effects of substances chiefly nonmedicinal as to source
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 189 | 92 | 97 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | 43.05 | 40.30 | 45.66 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 169
- Matched controls
- 1689
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T54.3
ICD-10 Finland
Toxic effect: Corrosive alkalis and alkali-like substances
2384.3
117.3
100
*
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
716.4
54.8
51
*
T54.2
ICD-10 Finland
Toxic effect: Corrosive acids and acid-like substances
+∞
39.1
36
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
20.3
27.7
42
27
T54.9
ICD-10 Finland
Toxic effect: Corrosive substance, unspecified
+∞
23.5
22
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
9.6
15.4
32
40
N05AH04
ATC
quetiapine; oral
4.7
14.9
59
174
N05AH03
ATC
olanzapine; systemic
7.6
14.9
36
58
T28.6
ICD-10 Finland
Corrosion of oesophagus
+∞
14.8
14
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.2
14.5
49
122
N05AA02
ATC
levomepromazine; systemic
12.5
13.5
24
22
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.0
13.0
62
215
T54.1
ICD-10 Finland
Toxic effect: Other corrosive organic compounds
+∞
12.7
12
*
N05AX08
ATC
risperidone; systemic
6.7
12.6
33
59
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
6.1
11.5
32
62
A02BC02
ATC
pantoprazole; systemic
3.1
10.9
111
650
N05BA06
ATC
lorazepam; systemic, sublingual
10.3
10.9
21
23
N03AG01
ATC
valproic acid; systemic, rectal
7.1
10.7
26
42
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.2
10.2
32
72
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.1
9.3
30
69
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.4
9.3
28
60
AA1AD
NOMESCO Finland
CT of head and brain
3.5
9.1
48
174
C07AA05
ATC
propranolol; systemic
3.5
9.0
45
157
N05BA01
ATC
diazepam; systemic, rectal
4.1
8.8
35
100
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
12.5
8.8
15
13
N05BA04
ATC
oxazepam; oral
3.1
8.7
56
233
N03AX09
ATC
lamotrigine; oral
6.5
8.6
22
38
N05AF03
ATC
chlorprothixene; systemic
9.3
8.5
17
20
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
15.5
8.3
13
9
N02BE01
ATC
paracetamol; systemic, rectal
3.5
8.3
148
1130
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
12.6
8.2
14
12
X78
ICD-10 Finland
Intentional self-harm by sharp object
35.2
8.2
10
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
9.2
8.0
16
19
N05CD07
ATC
temazepam; oral
4.8
7.8
26
62
N05AX12
ATC
aripiprazole; systemic
6.3
7.8
20
35
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
47.2
7.8
9
*
R11
ICD-10 Finland
Nausea and vomiting
4.5
7.6
27
69
N03AX16
ATC
pregabalin; oral
3.0
7.6
49
204
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.0
7.5
30
86
K22.2
ICD-10 Finland
Oesophageal obstruction
83.6
7.5
8
*
N05AN01
ATC
lithium; oral
11.6
7.4
13
12
X59
ICD-10 Finland
Exposure to unspecified factor
3.0
7.4
48
199
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.8
7.2
31
95
F60.9
ICD-10 Finland
Personality disorder, unspecified
12.8
7.2
12
10
N06AB03
ATC
fluoxetine; oral
3.9
7.1
29
85
N05CF01
ATC
zopiclone; oral
2.7
7.1
54
248
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
7.2
7.0
16
24
N03AE01
ATC
clonazepam; systemic
5.4
6.9
20
41
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
9.9
6.9
13
14
N06AX11
ATC
mirtazapine; oral
2.5
6.6
61
309
WX290
NOMESCO Finland
Other blockade of nerve
2.3
6.5
97
622
T26.6
ICD-10 Finland
Corrosion of cornea and conjunctival sac
72.4
6.5
7
*
Z91.5
ICD-10 Finland
Personal history of self-harm
72.4
6.5
7
*
P15
ICPC
Chronic alcohol abuse
8.7
6.5
13
16
UJD02
NOMESCO Finland
Gastroscopy
8.7
6.5
13
16
N03AX12
ATC
gabapentin; oral
3.4
6.5
31
104
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.8
6.3
17
32
N06AX16
ATC
venlafaxine; oral
3.2
6.3
35
129
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
18.9
6.3
9
5
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
18.9
6.3
9
5
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.1
6.3
24
66
S06.0
ICD-10 Finland
Concussion
3.5
6.3
29
94
SPAT1307
SPAT
Psychosocial counselling and guidance
3.8
6.3
26
77
Z72.8
ICD-10 Finland
Other problems related to lifestyle
27.8
6.3
8
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.5
6.2
29
95
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
13
16
8.65
9.85
4.2
2.9
2.1
1.7
mmol/l
0.49
13
16
45
173
3.10
9.10
1.9
1.7
1187.8
1174.3
nmol/l
0.04
36
137
25
65
4.28
9.02
6.5
8.7
25.0
24.5
mmol/l
0.30
25
65
63
296
2.69
8.78
1.6
1.9
0.6
1.0
mg/l
1.91
42
209
46
186
2.95
8.48
2.3
1.9
—
—
—
0
0
81
440
2.47
8.27
4.3
3.6
41.7
36.6
ng/l
0.07
53
258
15
27
5.95
8.16
4.6
2.2
24.9
24.8
mmol/l
0.04
15
21
78
420
2.46
8.08
4.5
2.8
53.0
55.4
u/l
0.36
73
389
50
225
2.66
7.46
4.3
3.0
247.5
152.3
ng/l
0.17
28
141
34
127
3.05
7.14
6.5
9.1
0.9
1.1
mmol/l
0.10
28
100
88
528
2.25
6.85
6.5
5.9
1.2
1.2
mmol/l
0.50
83
487
93
578
2.20
6.56
7.4
6.8
1.2
1.2
mmol/l
0.53
83
493
56
290
2.32
6.07
2.5
2.1
—
—
—
0
0
77
455
2.17
6.06
3.9
3.0
—
—
—
0
0
83
508
2.13
5.94
4.3
3.6
36.4
33.6
u/l
0.13
77
480
24
81
3.25
5.93
4.4
2.6
5.5
5.0
kpa
1.38
24
74
23
76
3.31
5.88
4.3
2.8
2.9
0.9
mmol/l
1.64
16
57
32
132
2.71
5.58
2.2
1.7
—
—
—
0
0
31
127
2.72
5.47
2.2
1.7
—
—
—
0
0
142
1086
2.24
5.44
8.8
7.4
79.7
75.2
u/l
0.66
136
1018
75
456
2.07
5.35
1.9
1.7
90.3
98.8
pmol/l
0.89
38
245
51
269
2.23
5.22
2.0
3.5
484.5
717.3
ng/l
0.82
42
226
11
23
5.02
5.08
16.5
13.2
1734.5
1618.1
nmol/l
0.12
11
23
118
862
1.98
4.85
12.2
9.3
4.5
4.0
e9/l
1.22
107
755
25
100
2.73
4.60
3.2
2.5
0.2
0.2
g/l
2.04
25
93
142
1121
2.07
4.51
4.9
3.7
14.4
14.7
pmol/l
0.54
133
1036
12
31
4.07
4.33
1.2
1.9
—
—
—
0
0
93
646
1.87
4.26
5.8
3.9
—
—
—
0
0
98
698
1.84
4.10
4.4
3.2
0.0
0.0
estimate
0.00
25
127
49
278
2.03
4.08
1.4
1.3
17.2
21.5
nmol/l
1.85
44
241
82
554
1.85
4.05
4.7
3.2
—
—
—
0
0
54
323
1.94
3.85
5.1
3.3
1.0
1.0
kg/l
0.11
11
37
58
356
1.91
3.83
4.0
2.8
0.2
0.5
e6/l
0.76
43
262
96
694
1.78
3.70
5.7
4.4
0.0
0.0
estimate
0.00
26
131
161
1371
2.18
3.63
6.2
4.2
1.8
1.8
mu/l
0.12
149
1276
97
707
1.76
3.61
4.5
3.2
0.0
0.0
estimate
0.00
23
125
8
13
6.37
3.54
12.5
9.8
0.7
0.6
mmol/l
—
8
13
155
1307
2.03
3.51
5.1
4.7
39.2
38.8
mmol/mol
0.15
146
1243
17
64
2.82
3.50
8.1
12.9
94.3
93.8
%
0.19
17
64
64
417
1.81
3.46
2.5
3.3
2.4
2.4
mmol/l
0.03
59
377
11
32
3.59
3.39
1.2
2.0
—
—
—
0
0
33
174
2.09
3.31
2.2
2.2
13.1
15.3
umol/l
0.72
28
160
57
363
1.82
3.30
5.3
3.4
0.0
0.0
estimate
0.00
26
126
11
33
3.48
3.24
2.1
2.0
0.5
0.8
ug/l
0.31
11
33
9
20
4.67
3.15
1.2
1.8
—
—
—
0
0
173
1547
2.40
2.95
23.7
11.4
23.4
22.8
mg/l
0.09
144
1171
40
236
1.88
2.92
2.2
1.7
173529843.4
459.6
pmol/l
0.49
34
211
9
22
4.24
2.92
1.2
1.8
—
—
—
0
0
73
524
1.64
2.67
2.3
2.3
73.3
74.2
nmol/l
0.08
67
478
36
212
1.86
2.64
3.3
2.4
1.1
0.7
e6/l
0.31
20
112
46
293
1.75
2.61
2.3
1.9
2.6
3.0
mg/l
0.50
40
249
13
50
2.72
2.59
1.9
1.4
—
—
—
0
0
34
198
1.87
2.58
4.0
2.5
3.0
2.3
e6/l
0.19
19
97
9
26
3.58
2.51
1.2
1.8
—
—
—
0
0
12
45
2.78
2.50
2.3
2.4
—
—
—
0
0
16
71
2.37
2.42
1.8
1.4
—
—
—
0
0
85
646
1.57
2.40
3.1
2.5
110.4
93.7
ug/l
0.29
80
604
5
8
6.38
2.38
2.4
2.6
—
—
—
0
0
27
151
1.92
2.31
2.3
2.2
21.8
26.3
%
0.81
20
125
19
93
2.16
2.31
2.1
2.3
15849.3
2425.1
u/l
—
6
40
6
13
4.73
2.29
1.0
1.3
—
—
—
0
0
11
42
2.72
2.22
2.2
2.1
—
—
—
0
0
13
55
2.46
2.17
3.6
2.4
25.1
24.0
mmol/l
0.75
13
50
6
14
4.39
2.17
1.0
1.4
—
—
—
0
0
8
25
3.29
2.12
1.1
1.8
—
—
—
0
0
8
26
3.17
2.04
1.3
1.2
—
—
—
0
0
134
1154
1.55
2.00
5.0
3.0
42.8
42.3
u/l
0.03
129
1106
22
121
1.93
1.98
10.3
20.6
1.1
1.3
inr
—
9
21
7
21
3.42
1.98
1.0
1.5
—
—
—
0
0
15
71
2.21
1.98
3.0
2.3
0.2
0.1
e6/l
0.39
15
66
55
395
1.55
1.93
1.3
1.3
1.9
1.3
u/ml
0.28
13
106
18
93
2.03
1.92
1.6
1.5
—
—
—
0
0
6
17
3.61
1.85
1.0
1.5
—
—
—
0
0
158
1427
1.65
1.79
18.1
9.9
95.1
91.4
ml/min/173m2
1.35
135
1137
9
36
2.57
1.76
1.6
1.5
0.5
0.4
nmol/l
—
9
27
6
18
3.41
1.76
1.2
1.8
—
—
—
0
0
27
166
1.73
1.73
3.4
3.0
4.6
10.7
umol/l
1.62
22
145
157
1421
1.62
1.70
4.9
3.7
6.0
5.8
mmol/l
0.50
148
1327
21
122
1.81
1.62
7.2
2.9
—
—
—
0
0
5
14
3.64
1.62
1.2
1.0
—
—
—
0
0
165
1523
1.66
1.51
20.6
11.7
40.1
41.3
%
0.87
120
1251
9
40
2.31
1.42
1.3
1.3
—
—
—
0
0
10
47
2.19
1.36
2.1
2.8
—
—
—
0
0
6
24
2.55
1.31
1.7
1.3
—
—
—
0
0
6
24
2.55
1.31
1.7
1.3
—
—
—
0
0
7
141
0.48
1.27
1.6
1.5
—
—
—
0
0
162
1507
1.52
1.21
4.8
4.1
2.7
2.8
mmol/l
2.00
149
1415
5
111
0.44
1.17
3.2
4.8
2.1
7.8
ug/l
—
5
91
15
89
1.74
1.11
4.2
2.4
93.3
74.4
ml/min/173m2
—
8
36
33
244
1.43
1.00
1.3
1.2
16.1
26.2
iu/ml
—
9
82
50
401
1.34
0.94
1.5
1.6
—
—
—
0
0
155
1450
1.38
0.93
4.1
3.4
1.4
1.3
mmol/l
0.36
143
1361
11
63
1.79
0.92
1.8
1.8
—
—
—
0
0
159
1495
1.40
0.91
4.6
3.8
4.6
4.7
mmol/l
0.78
148
1413
6
29
2.10
0.90
1.0
7.7
—
817.6
—
0
5
137
1263
1.31
0.88
3.8
3.5
—
—
—
0
0
14
90
1.60
0.80
3.0
3.9
4.8
4.8
pmol/l
0.03
14
80
13
197
0.63
0.80
1.6
1.7
—
—
—
0
0
30
228
1.38
0.79
1.6
1.2
18.5
4.8
u/ml
—
10
95
9
53
1.73
0.76
1.0
1.4
—
—
—
0
0
41
331
1.30
0.74
2.2
2.6
363.5
5225.4
umol/l
1.26
33
292
157
1492
1.31
0.67
4.4
3.8
1.4
1.4
mmol/l
0.10
146
1403
44
373
1.23
0.54
1.7
1.7
1.5
1.4
mmol/l
0.38
39
322
19
148
1.32
0.45
8.6
6.8
—
—
—
0
0
22
176
1.28
0.44
2.2
2.2
—
—
—
0
0
5
31
1.63
0.43
3.0
2.9
—
—
—
0
0
5
32
1.58
0.42
2.2
1.7
—
—
—
0
0
11
79
1.42
0.41
2.7
1.7
—
—
—
0
0
5
35
1.44
0.39
1.4
1.2
—
—
—
0
0
39
340
1.19
0.37
2.3
2.3
—
—
—
0
0
7
52
1.36
0.31
1.7
1.3
—
—
—
0
0
14
112
1.27
0.29
1.1
1.0
—
—
—
0
0
35
314
1.14
0.24
2.4
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
5.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
29
260
1.14
0.21
1.7
1.5
—
—
—
0
0
6
48
1.26
0.20
1.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
51
1.18
0.19
2.0
1.5
—
—
—
0
0
5
70
0.71
0.17
1.6
1.5
—
—
—
0
0
5
70
0.71
0.17
1.6
1.5
—
—
—
0
0
5
70
0.71
0.17
1.6
1.5
—
—
—
0
0
21
233
0.89
0.15
2.3
2.4
0.7
0.6
ug/l
0.14
14
115
35
326
1.09
0.13
3.6
3.6
22.9
22.1
%
0.08
16
114
16
144
1.12
0.11
2.1
2.1
—
—
—
0
0
9
104
0.86
0.06
1.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
25.5
—
0
6
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
7
75
0.93
0.00
1.4
1.6
—
—
—
0
0
5
57
0.87
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
120.4
—
0
7
5
54
0.92
0.00
1.2
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
2.6
—
109.9
—
0
8
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
2.8
—
13.7
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.2
—
55.8
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_TOXIC_EFFECT_CORROSIVE_SUBST – Toxic effect of corrosive substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).